Mary L. Gemignani

6.5k total citations
122 papers, 4.3k citations indexed

About

Mary L. Gemignani is a scholar working on Cancer Research, Surgery and Oncology. According to data from OpenAlex, Mary L. Gemignani has authored 122 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Cancer Research, 46 papers in Surgery and 44 papers in Oncology. Recurrent topics in Mary L. Gemignani's work include Breast Cancer Treatment Studies (66 papers), Breast Lesions and Carcinomas (41 papers) and Breast Implant and Reconstruction (34 papers). Mary L. Gemignani is often cited by papers focused on Breast Cancer Treatment Studies (66 papers), Breast Lesions and Carcinomas (41 papers) and Breast Implant and Reconstruction (34 papers). Mary L. Gemignani collaborates with scholars based in United States, Canada and Brazil. Mary L. Gemignani's co-authors include Richard R. Barakat, Nadeem R. Abu‐Rustum, Hiram S. Cody, Kimberly J. Van Zee, Patrick I. Borgen, S. Dennis, Jeanne A. Petrek, Alexandra S. Heerdt, Yukio Sonoda and Virgilio Sacchini and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Mary L. Gemignani

118 papers receiving 4.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary L. Gemignani United States 38 1.9k 1.6k 1.3k 1.2k 1.2k 122 4.3k
Carla C. Wárlám-Rodenhuis Netherlands 22 1.4k 0.7× 1.2k 0.8× 893 0.7× 2.4k 2.0× 907 0.8× 35 4.9k
Emmanuel Barranger France 34 1.4k 0.7× 1.3k 0.8× 778 0.6× 1.9k 1.5× 916 0.8× 229 4.2k
Jan J. Jobsen Netherlands 35 1.4k 0.8× 1.1k 0.7× 1.1k 0.9× 4.3k 3.5× 951 0.8× 92 6.4k
J Dauplat France 30 1.0k 0.6× 828 0.5× 1.2k 0.9× 648 0.5× 671 0.6× 184 3.1k
Éric Lambaudie France 29 781 0.4× 1.3k 0.8× 708 0.6× 1.0k 0.8× 404 0.3× 176 2.9k
Matthew A. Powell United States 40 747 0.4× 837 0.5× 1.1k 0.9× 3.3k 2.6× 748 0.6× 182 5.7k
Jeffrey D. Seidman United States 42 565 0.3× 1.5k 1.0× 725 0.6× 2.2k 1.8× 715 0.6× 105 5.5k
Catherine Uzan France 33 468 0.3× 953 0.6× 779 0.6× 1.7k 1.4× 260 0.2× 204 3.9k
Catheryn M. Yashar United States 32 582 0.3× 1.2k 0.7× 578 0.5× 1.8k 1.5× 275 0.2× 149 3.5k
Anne de la Rochefordière France 26 1.6k 0.8× 591 0.4× 1.1k 0.9× 307 0.2× 832 0.7× 79 2.7k

Countries citing papers authored by Mary L. Gemignani

Since Specialization
Citations

This map shows the geographic impact of Mary L. Gemignani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary L. Gemignani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary L. Gemignani more than expected).

Fields of papers citing papers by Mary L. Gemignani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary L. Gemignani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary L. Gemignani. The network helps show where Mary L. Gemignani may publish in the future.

Co-authorship network of co-authors of Mary L. Gemignani

This figure shows the co-authorship network connecting the top 25 collaborators of Mary L. Gemignani. A scholar is included among the top collaborators of Mary L. Gemignani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary L. Gemignani. Mary L. Gemignani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Crown, Angelena, Damian McCartan, Michael Curry, et al.. (2023). Pregnancy-associated breast cancer: does timing of presentation affect outcome?. Breast Cancer Research and Treatment. 198(2). 283–294. 2 indexed citations
3.
Pak, Linda M., et al.. (2023). Long-Term Patient-Reported Outcomes Comparing Oncoplastic Breast Surgery and Conventional Breast-Conserving Surgery: A Propensity Score-Matched Analysis. Annals of Surgical Oncology. 30(12). 7091–7098. 4 indexed citations
4.
Verdial, Francys C., Anita Mamtani, Varadan Sevilimedu, et al.. (2022). The Effect of Age on Outcomes After Neoadjuvant Chemotherapy for Breast Cancer. Annals of Surgical Oncology. 29(6). 3810–3819. 21 indexed citations
5.
Gemignani, Mary L., et al.. (2021). ASO Author Reflections: Stage IV Pregnancy-Associated Breast Cancer: A Continuum of Disease. Annals of Surgical Oncology. 29(3). 1703–1704. 1 indexed citations
6.
Walsh, Siún, Sandra Brennan, Emily C. Zabor, et al.. (2019). Does Breast Density Increase the Risk of Re-excision for Women with Breast Cancer Having Breast-Conservation Therapy?. Annals of Surgical Oncology. 26(13). 4246–4253. 10 indexed citations
7.
Zabor, Emily C., et al.. (2019). Contralateral Prophylactic Mastectomy Use After Neoadjuvant Chemotherapy. Annals of Surgical Oncology. 27(3). 743–749. 7 indexed citations
8.
Cordeiro, Christina N. & Mary L. Gemignani. (2017). Gynecologic Malignancies in Pregnancy: Balancing Fetal Risks With Oncologic Safety. Obstetrical & Gynecological Survey. 72(3). 184–193. 35 indexed citations
9.
Morrow, Monica, Kimberly J. Van Zee, Sujata Patil, et al.. (2017). Axillary Dissection and Nodal Irradiation Can Be Avoided for Most Node-positive Z0011-eligible Breast Cancers. Annals of Surgery. 266(3). 457–462. 81 indexed citations
10.
Mamtani, Anita, Andrea V. Barrio, Tari A. King, et al.. (2016). How Often Does Neoadjuvant Chemotherapy Avoid Axillary Dissection in Patients With Histologically Confirmed Nodal Metastases? Results of a Prospective Study. Annals of Surgical Oncology. 23(11). 3467–3474. 226 indexed citations
11.
O’Brien, Julie A., Alice Y. Ho, Michelle Stempel, et al.. (2015). Breast-Conserving Surgery in Bilateral Breast Cancer. Annals of Surgical Oncology. 22(10). 3389–3396. 19 indexed citations
12.
Gemignani, Mary L., Sujata Patil, Venkatraman Seshan, et al.. (2013). Feasibility and Predictability of Perioperative PET and Estrogen Receptor Ligand in Patients with Invasive Breast Cancer. Journal of Nuclear Medicine. 54(10). 1697–1702. 55 indexed citations
13.
Barry, Mitchel & Mary L. Gemignani. (2011). Follow-Up for Women with Abnormal Mammograms. Journal watch. 2011. 2 indexed citations
14.
Gemignani, Mary L.. (2011). Breast Cancer Screening. Clinical Obstetrics & Gynecology. 54(1). 125–132. 11 indexed citations
15.
Diaz, John P., Mary L. Gemignani, Neeta Pandit‐Taskar, et al.. (2011). Sentinel lymph node biopsy in the management of early-stage cervical carcinoma. Gynecologic Oncology. 120(3). 347–352. 66 indexed citations
16.
Gemignani, Mary L.. (2010). The New Mammographic Screening Guidelines. Obstetrics and Gynecology. 115(3). 484–486. 3 indexed citations
17.
Abu‐Rustum, Nadeem R., Yukio Sonoda, & Mary L. Gemignani. (2006). Sentinel lymph node identification for early-stage cervical cancer. Gynecologic Oncology. 104(2). 2–4. 4 indexed citations
18.
Naik, Arpana, Jane V. Fey, Mary L. Gemignani, et al.. (2004). The Risk of Axillary Relapse After Sentinel Lymph Node Biopsy for Breast Cancer Is Comparable With That of Axillary Lymph Node Dissection. Annals of Surgery. 240(3). 462–471. 297 indexed citations
19.
Gemignani, Mary L. & Jeanne A. Petrek. (1999). Pregnancy after Breast Cancer. Cancer Control. 6(3). 1–4. 18 indexed citations
20.
Gemignani, Mary L., Jeanne A. Petrek, & Patrick I. Borgen. (1999). BREAST CANCER AND PREGNANCY. Surgical Clinics of North America. 79(5). 1157–1169. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carla C. Wárlám-Rodenhuis Breakdown of academic impact, for papers by Emmanuel Barranger Breakdown of academic impact, for papers by Jan J. Jobsen Breakdown of academic impact, for papers by J Dauplat Breakdown of academic impact, for papers by Éric Lambaudie Breakdown of academic impact, for papers by Matthew A. Powell Breakdown of academic impact, for papers by Jeffrey D. Seidman Breakdown of academic impact, for papers by Catherine Uzan Breakdown of academic impact, for papers by Catheryn M. Yashar Breakdown of academic impact, for papers by Anne de la Rochefordière
Rankless by CCL
2026